Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Study to Assess Efficacy and Safety of LN-145/LN-145-S1 (Autologous Centrally Manufactured Tumor Infiltrating Lymphocytes) Across Multiple Tumor Types

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03449108
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:56.634917+00:00
Published At
2025-11-21T00:00:00+00:00
Record Updated At
2025-11-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Bone Sarcoma", "Dedifferentiated Chondrosarcoma", "Giant Cell Tumor of Bone", "Malignancy in Giant Cell Tumor of Bone", "Malignant Solid Neoplasm", "Ovarian Carcinosarcoma", "Platinum-Resistant Ovarian Carcinoma", "Poorly Differentiated Thyroid Gland Carcinoma", "Recurrent Osteosarcoma", "Recurrent Ovarian Carcinoma", "Refractory Osteosarcoma", "Soft Tissue Sarcoma", "Thyroid Gland Anaplastic Carcinoma", "Thyroid Gland Squamous Cell Carcinoma", "Undifferentiated High Grade Pleomorphic Sarcoma of Bone", "Triple Negative Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-21"
protocolSection.identificationModule.nctId
"NCT03449108"
protocolSection.identificationModule.officialTitle
"Clinical Study to Assess Efficacy and Safety of LN-145/LN-145-S1 (Autologous Centrally Manufactured Tumor Infiltrating Lymphocytes) Across Multiple Tumor Types"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Bone Sarcoma (protocolSection.conditionsModule.conditions)
  • Dedifferentiated Chondrosarcoma (protocolSection.conditionsModule.conditions)
  • Giant Cell Tumor of Bone (protocolSection.conditionsModule.conditions)
  • Malignancy in Giant Cell Tumor of Bone (protocolSection.conditionsModule.conditions)
  • Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Ovarian Carcinosarcoma (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Poorly Differentiated Thyroid Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Osteosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Osteosarcoma (protocolSection.conditionsModule.conditions)
  • Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Thyroid Gland Anaplastic Carcinoma (protocolSection.conditionsModule.conditions)
  • Thyroid Gland Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Undifferentiated High Grade Pleomorphic Sarcoma of Bone (protocolSection.conditionsModule.conditions)
  • Triple Negative Breast Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.